Caroline Pabst

17PUBLICATIONS
111CO-AUTHORS
Cellular immunologyGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 26, 2026
Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma.

Felix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile

|Sep 18, 2024
Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML.

Julia M Unglaub, Richard F Schlenk, Jan Moritz Middeke

|Jan 10, 2024
The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature.

Anna Mathioudaki, Xizhe Wang, David Sedloev

|Jul 06, 2023
The ribosomal protein S6 kinase alpha-1 (RPS6KA1) induces resistance to venetoclax/azacitidine in acute myeloid leukemia.

Katharina Weidenauer, Christina Schmidt, Christian Rohde

|Mar 09, 2023
Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.

Alexander Waclawiczek, Aino-Maija Leppä, Simon Renders

|Oct 19, 2022
A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia.

Fengbiao Zhou, Nesrine Aroua, Yi Liu

Pageof 3

Frequent Collaborators

11 joint publications

Carsten Müller-Tidow

5 joint publications

Andreas Trumpp

5 joint publications

Judith Zaugg

4 joint publications

Christoph Röllig